205 related articles for article (PubMed ID: 20480028)
1. Differential proteomics identification of HSP90 as potential serum biomarker in hepatocellular carcinoma by two-dimensional electrophoresis and mass spectrometry.
Sun Y; Zang Z; Xu X; Zhang Z; Zhong L; Zan W; Zhao Y; Sun L
Int J Mol Sci; 2010 Mar; 11(4):1423-33. PubMed ID: 20480028
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneous nuclear ribonucleoprotein K (hnRNP K) is a tissue biomarker for detection of early hepatocellular carcinoma in patients with cirrhosis.
Guo Y; Zhao J; Bi J; Wu Q; Wang X; Lai Q
J Hematol Oncol; 2012 Jul; 5():37. PubMed ID: 22760167
[TBL] [Abstract][Full Text] [Related]
3. Global proteomic profiling in multistep hepatocarcinogenesis and identification of PARP1 as a novel molecular marker in hepatocellular carcinoma.
Xu X; Liu Z; Wang J; Xie H; Li J; Cao J; Zhou L; Zheng S
Oncotarget; 2016 Mar; 7(12):13730-41. PubMed ID: 26883192
[TBL] [Abstract][Full Text] [Related]
4. Predicting early intrahepatic recurrence of hepatocellular carcinoma after microwave ablation using SELDI-TOF proteomic signature.
Cao XL; Li H; Yu XL; Liang P; Dong BW; Fan J; Li M; Liu FY
PLoS One; 2013; 8(12):e82448. PubMed ID: 24349287
[TBL] [Abstract][Full Text] [Related]
5. Proteomic identification of CIB1 as a potential diagnostic factor in hepatocellular carcinoma.
Junrong T; Huancheng Z; Feng H; Yi G; Xiaoqin Y; Zhengmao L; Hong Z; Jianying Z; Yin W; Yuanhang H; Jianlin Z; Longhua S; Guolin H
J Biosci; 2011 Sep; 36(4):659-68. PubMed ID: 21857112
[TBL] [Abstract][Full Text] [Related]
6. Novel proteomic biomarker panel for prediction of aggressive metastatic hepatocellular carcinoma relapse in surgically resectable patients.
Tan GS; Lim KH; Tan HT; Khoo ML; Tan SH; Toh HC; Ching Ming Chung M
J Proteome Res; 2014 Nov; 13(11):4833-46. PubMed ID: 24946162
[TBL] [Abstract][Full Text] [Related]
7. Inter-alpha Inhibitor H4 as a Potential Biomarker Predicting the Treatment Outcomes in Patients with Hepatocellular Carcinoma.
Lee EJ; Yang SH; Kim KJ; Cha H; Lee SJ; Kim JH; Song J; Chun KH; Seong J
Cancer Res Treat; 2018 Jul; 50(3):646-657. PubMed ID: 28724284
[TBL] [Abstract][Full Text] [Related]
8. Biomarker discovery for early detection of hepatocellular carcinoma in hepatitis C-infected patients.
Mustafa MG; Petersen JR; Ju H; Cicalese L; Snyder N; Haidacher SJ; Denner L; Elferink C
Mol Cell Proteomics; 2013 Dec; 12(12):3640-52. PubMed ID: 24008390
[TBL] [Abstract][Full Text] [Related]
9. Proteomics for hepatocellular carcinoma marker discovery.
Chignard N; Beretta L
Gastroenterology; 2004 Nov; 127(5 Suppl 1):S120-5. PubMed ID: 15508075
[TBL] [Abstract][Full Text] [Related]
10. Identification of candidate biomarkers for hepatocellular carcinoma in plasma of HCV-infected cirrhotic patients by 2-D DIGE.
Ferrín G; Ranchal I; Llamoza C; Rodríguez-Perálvarez ML; Romero-Ruiz A; Aguilar-Melero P; López-Cillero P; Briceño J; Muntané J; Montero-Álvarez JL; De la Mata M
Liver Int; 2014 Mar; 34(3):438-46. PubMed ID: 23944848
[TBL] [Abstract][Full Text] [Related]
11. From proteomic analysis to clinical significance: overexpression of cytokeratin 19 correlates with hepatocellular carcinoma metastasis.
Ding SJ; Li Y; Tan YX; Jiang MR; Tian B; Liu YK; Shao XX; Ye SL; Wu JR; Zeng R; Wang HY; Tang ZY; Xia QC
Mol Cell Proteomics; 2004 Jan; 3(1):73-81. PubMed ID: 14593079
[TBL] [Abstract][Full Text] [Related]
12. Proteomic profiling of hepatocellular carcinoma in Chinese cohort reveals heat-shock proteins (Hsp27, Hsp70, GRP78) up-regulation and their associated prognostic values.
Luk JM; Lam CT; Siu AF; Lam BY; Ng IO; Hu MY; Che CM; Fan ST
Proteomics; 2006 Feb; 6(3):1049-57. PubMed ID: 16400691
[TBL] [Abstract][Full Text] [Related]
13. Serum and tissue proteomic signatures of patients with hepatocellular carcinoma using 2‑D gel electrophoresis.
Peng H; Yan Z; Zeng X; Zhang S; Jiang H; Huang H; Zhuo H
Mol Med Rep; 2019 Aug; 20(2):1025-1038. PubMed ID: 31173207
[TBL] [Abstract][Full Text] [Related]
14. [Stable isotope labeling and parallel reaction monitoring-based proteomic quantification for biomarker screening and validation of hepatocellular carcinoma].
Wang S; Gao H; Zhang J; Ye X
Se Pu; 2017 Sep; 35(9):934-940. PubMed ID: 29048850
[TBL] [Abstract][Full Text] [Related]
15. Glutamine synthetase as an early marker for hepatocellular carcinoma based on proteomic analysis of resected small hepatocellular carcinomas.
Long J; Lang ZW; Wang HG; Wang TL; Wang BE; Liu SQ
Hepatobiliary Pancreat Dis Int; 2010 Jun; 9(3):296-305. PubMed ID: 20525558
[TBL] [Abstract][Full Text] [Related]
16. Protein profiling in hepatocellular carcinoma by label-free quantitative proteomics in two west African populations.
Fye HK; Wright-Drakesmith C; Kramer HB; Camey S; Nogueira da Costa A; Jeng A; Bah A; Kirk GD; Sharif MI; Ladep NG; Okeke E; Hainaut P; Taylor-Robinson SD; Kessler BM; Mendy ME
PLoS One; 2013; 8(7):e68381. PubMed ID: 23935864
[TBL] [Abstract][Full Text] [Related]
17. Proteomic differences between hepatocellular carcinoma and nontumorous liver tissue investigated by a combined gel-based and label-free quantitative proteomics study.
Megger DA; Bracht T; Kohl M; Ahrens M; Naboulsi W; Weber F; Hoffmann AC; Stephan C; Kuhlmann K; Eisenacher M; Schlaak JF; Baba HA; Meyer HE; Sitek B
Mol Cell Proteomics; 2013 Jul; 12(7):2006-20. PubMed ID: 23462207
[TBL] [Abstract][Full Text] [Related]
18. LC-MS based serum metabolomics for identification of hepatocellular carcinoma biomarkers in Egyptian cohort.
Xiao JF; Varghese RS; Zhou B; Nezami Ranjbar MR; Zhao Y; Tsai TH; Di Poto C; Wang J; Goerlitz D; Luo Y; Cheema AK; Sarhan N; Soliman H; Tadesse MG; Ziada DH; Ressom HW
J Proteome Res; 2012 Dec; 11(12):5914-23. PubMed ID: 23078175
[TBL] [Abstract][Full Text] [Related]
19. [Comparative proteomic approach in differentiating multicentric occurrence and intrahepatic metastasis in multinodular hepatocellular carcinomas].
Su M; Li LQ; Peng T; Guo Y; Xiao KY; Shang LM; Xu BH; Li SL; Su ZX; Ye XP
Chin J Cancer; 2010 Jan; 29(1):52-8. PubMed ID: 20038311
[TBL] [Abstract][Full Text] [Related]
20. Identification of human hepatocellular carcinoma-related proteins by proteomic approaches.
Yang MH; Tyan YC; Jong SB; Huang YF; Liao PC; Wang MC
Anal Bioanal Chem; 2007 Jun; 388(3):637-43. PubMed ID: 17447055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
